Posterior reversible encephalopathy syndrome with concurrent nephrotic syndrome in a patient treated with pazopanib for metastatic renal cell carcinoma: case report and review of the literature.
Affiliation
3rd Department of Medical Oncology, 'Agii Anargiri' General Oncology Hospital of Kifissia, N. Kifissia, Athens, GreeceIssue Date
2016-08-10
Metadata
Show full item recordCitation
Posterior reversible encephalopathy syndrome with concurrent nephrotic syndrome in a patient treated with pazopanib for metastatic renal cell carcinoma: case report and review of the literature. 2016, Clin Genitourin CancerJournal
Clinical Genitourinary CancerDOI
10.1016/j.clgc.2016.08.005PubMed ID
27601362Type
ArticleLanguage
enISSN
1938-0682ae974a485f413a2113503eed53cd6c53
10.1016/j.clgc.2016.08.005
Scopus Count
Collections
Related articles
- Pazopanib-associated posterior reversible encephalopathy syndrome with intracerebral haemorrhage.
- Authors: Miller-Patterson C, Fehnel CR
- Issue date: 2017 Apr 17
- Reversible posterior leukoencephalopathy syndrome induced by pazopanib.
- Authors: Chelis L, Souftas V, Amarantidis K, Xenidis N, Chamalidou E, Dimopoulos P, Michailidis P, Christakidis E, Prassopoulos P, Kakolyris S
- Issue date: 2012 Oct 22
- Posterior reversible encephalopathy syndrome induced by pazopanib for renal cell carcinoma.
- Authors: Asaithambi G, Peters BR, Hurliman E, Moran BP, Khan AS, Taylor RA
- Issue date: 2013 Apr
- Reversible posterior leukoencephalopathy syndrome induced by axitinib.
- Authors: Levy A, Benmoussa L, Ammari S, Albiges L, Escudier B
- Issue date: 2014 Feb
- Posterior reversible encephalopathy syndrome (PRES) induced by pazopanib, a multi-targeting tyrosine kinase inhibitor, in a patient with soft-tissue sarcoma: case report and review of the literature.
- Authors: Deguchi S, Mitsuya K, Nakasu Y, Hayashi N, Katagiri H, Murata H, Wasa J, Takahashi M, Endo M
- Issue date: 2018 Apr